- 1.
- 2.Definium Notches Second Positive Phase 3 in Generalised Anxiety Disorder (psychedelicalpha.com)
- 3.Two New Zealand Psychiatrists Approved to Prescribe MDMA for PTSD (psychedelicalpha.com)
- 4.MAPS Announces Agreement with UAB (maps.org)
- 5.
- 7.Credentials, Clinics, and Costs: Stakeholders Respond to HRSA’s Psychedelic Therapy RFI (psychedelicalpha.com)
- 8.Scoop: Johnson & Johnson to Lead Delix Therapeutics’ $85M Series C (psychedelicalpha.com)
- 9.Two Years After Rejection, Resilient Quietly Refiles MDMA for PTSD Application (psychedelicalpha.com)
- 11.
- 16.
- 17.Field Notes #1: Psychiatrists, Regulators, Ibogaine, and the Race for Psilocybin Approval (psychedelicalpha.com)
- 18.Bit Yaden on Preparing the Next Generation of Psychiatrists for a Psychedelic Future (psychedelicalpha.com)
- 21.Psilocybin for Cocaine Use Disorder: Peter Hendricks on a Trial Ten Years in the Making (psychedelicalpha.com)
- 22.What does art have to offer to psychedelic therapy? (chacruna.net)
- 23.Protected: RELOCATING THE ROOT (maps.org)
- 24.
- 26.“Magic Mushrooms” and the Treatment of Mental Illness - Psychology Today (news.google.com)
- 27.“Magic Mushrooms” and the Treatment of Mental Illness - Psychology Today (news.google.com)
- 29.Remembering Nolan Williams, M.D. (maps.org)
- 30.